HKSE:03759 has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HKSE:03759 has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Pharmaron Beijing Co's change in inventory for the quarter that ended in Mar. 2025 was HK$0 Mil. It means Pharmaron Beijing Co's inventory stayed the same from Dec. 2024 to Mar. 2025 .
Pharmaron Beijing Co's change in inventory for the fiscal year that ended in Dec. 2024 was HK$-158 Mil. It means Pharmaron Beijing Co's inventory increased by HK$158 Mil from Dec. 2023 to Dec. 2024 .
Pharmaron Beijing Co's Total Inventories for the quarter that ended in Mar. 2025 was HK$1,251 Mil.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Pharmaron Beijing Co's Days Inventory for the quarter that ended in Mar. 2025 was 50.57.
Inventory Turnover measures how fast the company turns over its inventory within a year. Pharmaron Beijing Co's Inventory Turnover for the quarter that ended in Mar. 2025 was 1.80.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Pharmaron Beijing Co's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 0.37.
The historical data trend for Pharmaron Beijing Co's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmaron Beijing Co Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
Change In Inventory | Get a 7-Day Free Trial |
![]() |
![]() |
-142.31 | -275.35 | -135.00 | 90.16 | -158.09 |
Pharmaron Beijing Co Quarterly Data | ||||||||||||||||||||
Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | Mar25 | |
Change In Inventory | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
- | - | - | - | - |
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmaron Beijing Co (HKSE:03759) Change In Inventory Explanation
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Pharmaron Beijing Co's Days Inventory for the quarter that ended in is calculated as:
Days Inventory | = | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period |
= | 1221.528 | / | 2204.365 | * | 365 / 4 | |
= | 50.57 |
2. Inventory Turnover measures how fast the company turns over its inventory within a year.
Pharmaron Beijing Co's Inventory Turnover for the quarter that ended in Mar. 2025 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 2204.365 | / | 1221.528 | |
= | 1.80 |
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Pharmaron Beijing Co's Inventory to Revenue for the quarter that ended in Mar. 2025 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 1221.528 | / | 3322.591 | |
= | 0.37 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Pharmaron Beijing Co's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Hsbc Holdings Plc | 2106 Person having a security interest in shares | |
Jpmorgan Chase & Co. | 2201 Interest of corporation controlled by you | |
Morgan Stanley | 2201 Interest of corporation controlled by you | |
The Bank Of New York Mellon Corporation | 2201 Interest of corporation controlled by you | |
Citigroup Inc. | 2201 Interest of corporation controlled by you | |
Blackrock, Inc. | 2201 Interest of corporation controlled by you | |
Gic Private Limited | 2102 Investment manager | |
The Capital Group Companies, Inc. | 2201 Interest of corporation controlled by you | |
Matthews International Capital Management, Llc | 2102 Investment manager | |
First H Share Award And Scheme Of Pharmaron Beijing Co., Ltd. | 2301 Trustee | |
Kastle Limited | 2301 Trustee | |
Jian Xin Bei Jing Tou Zi Ji Jin Guan Li You Xian Ze Ren Gong Si | 2201 Interest of corporation controlled by you | |
Jian Xin Xin Tuo You Xian Ze Ren Gong Si | 2201 Interest of corporation controlled by you |
No Headlines
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.